Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyResearch in context

Summary: Background: Although Ki-67 is a commonly used proliferation marker in breast cancer (BC), its prognostic value after neoadjuvant chemotherapy (NACT) remains unclear. This study aims to investigate the prognostic implications of Ki-67 dynamics during NACT. Methods: Patients with invasive BC...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Maria Angeliki Toli, Xingrong Liu, Davide Massa, Stefania Lando, Caroline Boman, Nikolaos Tsiknakis, Christian Tranchell, Andri Papakonstantinou, Giuseppe Fotia, Claudio Vernieri, Valentina Guarneri, Jonas Bergh, Maria Vittoria Dieci, Louise Eriksson Bergman, Alexios Matikas, Theodoros Foukakis
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-11-01
Saila:	The Lancet Regional Health. Europe
Gaiak:	Breast cancer Neoadjuvant chemotherapy Ki-67 Prognosis Survival Stratification
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2666776225002248
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!